Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 InhibitorsMohamed Shanavas, Vikas Gupta, Brenda Ernst et al.|Biology of Blood and Marrow Transplantation|2015Cited by 142
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchMichelle Long Schoettler, Sumithira Vasu, Kristin Page et al.|Transplantation and Cellular Therapy|2022Cited by 130
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndromeAdam S. Kittai, Samantha Jaglowski, John C. Byrd et al.|Blood Advances|2020Cited by 70
Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes RegistryRachel Cusatis, Bronwen E. Shaw, Lori Muffly et al.|Transplantation and Cellular Therapy|2021Cited by 13